2023’s Most Impactful Hospice Deals

2023’s Most Impactful Hospice Deals
Hospice News
December 5, 2023
A rich mix of hospice merger and acquisition activity at the end of 2023 is fueling trends into next year. Hospice M&A activity has diverged from the frenzied pace set in recent years. The hospice space in the last five years has seen record-breaking multiples, a prevalence of private equity-backed platform transactions and large-scale assets up for grabs. This year saw a slow but significant start, with mainly smaller and fewer hospice transactions taking place. As valuations have come down, asset sizes have varied and the scope of buyers has pivoted. However, the hospice market also saw a number of multi-billion-dollar “mega-deals” involving payers that stand to reshape aspects of the industry. The forthcoming sale of Amedisys to Optum marks one of the most significant transactions in the hospice industry in terms of valuation and buyer trends.